Patent Assignment
Reel/Frame 034421/0863
Release of Security Interest
Recorded: 2014-11-24
Pages: 5
Assignees
ADVANCED CELL TECHNOLOGY, INC.
33 LOCKE DRIVE, MARLBOROUGH, MASSACHUSETTS, 01752
MYTOGEN, INC.
33 LOCKE DRIVE, MARLBOROUGH, MASSACHUSETTS, 01752
Covered Properties
(54)
Muscle cells and their use in cardiac repair
Application:
10/105,035 →
Publication:
US US20030113301A1
De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
Application:
11/842,074 →
Publication:
US US20080076176A1
Methods of Reprogramming Animal Somatic Cells
Application:
11/989,988 →
Publication:
US US20100167404A1
Differentiating Es Cells Using a Tenascin
Methods of Producing RPE Cells and Compositions of RPE Cells
Application:
12/682,712 →
Publication:
US US20110274662A1
Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof
Application:
12/700,545 →
Publication:
US US20110171185A1
Modalities for the Treatment of Degenerative Diseases of the Retina
Genetically Intact Induced Pluripotent Cells Or Transdifferentiated Cells And Methods For The Production Thereof
Application:
12/787,175 →
Publication:
US US20110286978A1
Methods Of Producing Pluripotent Stem Cell-Generated Embryos, And Animals Derived Therefrom
Application:
12/809,704 →
Publication:
US US20110028780A1
Methods of Reprogramming Animal Somatic Cells
Application:
12/856,043 →
Publication:
US US20110143441A1
Methods For Producing Enriched Populations of Human Retinal Pigment Epithelium Cells
Hemangio Colony Forming Cells and Non-Engrafting Hemangio Cells
Methods for Producing Enucleated Erythroid Cells Derived from Pluripotent Stem Cells
Application:
12/991,111 →
Publication:
US US20110086424A1
Methods and Compositions For Reprogramming Cells
Application:
13/006,064 →
Publication:
US US20120184035A1
Tri-Circular Exercise Device with Variable Rotation Resistance
Application:
13/109,666 →
Publication:
US US20110287914A1
Hemangio-Colony Forming Cells
Application:
13/190,988 →
Publication:
US US20120027731A1
Methods of repairing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
Application:
13/336,755 →
Publication:
US US20120196769A1
Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
Application:
13/432,316 →
Publication:
US US20130058900A1
Laser Isolation of Viable Cells
Application:
13/441,617 →
Publication:
US US20120258451A1
Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture
Application:
13/447,439 →
Publication:
US US20130065307A1
Modalities for the Treatment of Degenerative Diseases of the Retina
Methods of Producing Human Rpe Cells and Pharmaceutical Preparations of Human Rpe Cells
Totipotent, Nearly Totipotent or Pluripotent Mammalian Cells Homozygous or Hemizygous for One or More Histocompatibility Antigens Genes
Application:
13/585,380 →
Publication:
US US20130053278A1
Catheter-Based Delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts
Application:
13/587,332 →
Publication:
US US20130041348A1
Cytoplasmic Transfer to De-Differentiate Recipient Cells
Application:
13/617,988 →
Publication:
US US20130104253A1
Methods for Making and Using Reprogrammed Human Somatic Cell Nuclei and Autologous and Isogenic Human Stem Cells
Application:
13/653,094 →
Publication:
US US20130102073A1
Pharmaceutical Preparations of Human Rpe Cells and Uses Thereof
Application:
13/676,999 →
Publication:
US US20130195806A1
Mesenchymal Stromal Cells and Uses Related Thereto
Generation of Histocompatible Tissues Using Nuclear Transplantation
Application:
13/691,568 →
Publication:
US US20130295056A1
Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
Parthenogenic Oocyte Activation
Patent:
6,077,710 →
Application:
09/176,395 →
Transplants for Myocardial Scars and Methods and Cellular Preparations
Patent:
6,110,459 →
Application:
08/863,882 →
Embryonic Stem Cells Capable of Differentiating into Desired Cell Lines
Patent:
6,432,711 →
Application:
08/333,076 →
Process for Sensing and Analyzing Electrical Activity of the Human Heart Utilizing One Lead System with an Egg Monitor Designed for Use with Another Lead System
Patent:
6,496,720 →
Application:
09/493,780 →
Muscle Cells and Their Use in Cardiac Repair
Patent:
6,673,604 →
Application:
09/624,885 →
In Vitro Activation of Mammalian Oocytes
Patent:
6,680,199 →
Application:
09/576,592 →
Method of Manufacturing Secondary Battery
Methods, Systems and Compositions for Monitoring Enzyme Activity and Applications Thereof
Trans-Differentiation and Re-Differentiation of Somatic Cells and Production of Cells for Cell Therapies
Embryonic or Stem-Like Cell Lines Produced by Cross Species Nuclear Transplantation and Methods for Enhancing Embryonic Development by Genetic Alteration of Donor Cells or by Tissue Culture Conditions
Methods for Producing Enriched Populations of Human Retinal Pigment Epithelium Cells
Methods for Producing Enriched Populations of Human Retinal Pigment Epithelium Cells for Treatment of Retinal Degeneration
Methods for Producing Enriched Populations of Human Retinal Pigment Epithelium Cells
Derivation of Embryonic Stem Cells
Derivation of Embryonic Stem Cells and Embryo-Derived Cells
Novel Culture Systems for Ex Vivo Development
Solution Temperature Control Device in Cell Observation Chamber
Methods for Producing Enriched Populations of Human Retinal Pigment Epithelium Cells for Treatment of Retinal Degeneration
Novel Culture Systems for Ex Vivo Development
Derivation of Embryonic Stem Cells
Derivation of Embryonic Stem Cells and Embryo-Derived Cells
Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells
Blastomere Culture to Produce Mammalian Embryonic Stem Cells
Method for Generating Immune-Compatible Cells and Tissues Using Nuclear Transfer Techniques
Patent:
6,808,704 →
Application:
09/655,815 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jan 25, 2013
From: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
To: CAMOFI MASTER LDC; CAMHZN MASTER LDC
Reel/Frame 029698/0001 →
Assignment of Assignor's Interest
Mar 26, 2013
From: LEMIEUX, LINDA; HOLMES, WILLIAM; MALCUIT, CHRISTOPHER
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 030083/0092 →
Assignment of Assignor's Interest
Jan 16, 2014
From: VILNER, LUCY
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 031990/0292 →
Assignment of Assignor's Interest
Oct 23, 2014
From: KLIMANSKAYA, IRINA V.
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 034023/0115 →
Confirmatory Assignment
Oct 23, 2014
From: LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 034038/0172 →
Assignment of Assignor's Interest
Oct 23, 2014
From: KLIMANSKAYA, IRINA; LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 034023/0059 →
Change of Name
Jan 7, 2015
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 034749/0622 →
Change of Name
Feb 10, 2015
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 034944/0418 →
Change of Name
Feb 13, 2015
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 034999/0826 →
Change of Name
Apr 1, 2015
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 035354/0207 →
Change of Name
Feb 4, 2016
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 037701/0117 →
Change of Name
Jul 27, 2016
From: OCATA THERAPEUTICS, INC.
To: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
Reel/Frame 039493/0166 →
Change of Name
May 31, 2017
From: OCATA THERAPEUTICS, INC.
To: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
Reel/Frame 042634/0795 →
Assignment of Assignor's Interest
Aug 2, 2019
From: HUERTAS, PEDRO
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 049938/0472 →
Confirmatory Assignment
Apr 5, 2024
From: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 067024/0057 →